Immunyx Pharma vs NewStem
Immunyx Pharma vs NewStem, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunyx Pharma is on 46/100 and NewStem on 45/100.
Where each one leads
Immunyx Pharma
- domain rating: 6/100 against 4/100
NewStem
- agent readiness: 50/100 against 41/100
At a glance
| Measure | Immunyx Pharma | NewStem |
|---|---|---|
| What it is | Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases. | Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy. |
| Category | Life Sciences, Biopharmaceutical, Drug Development, Biotech | Life Sciences, Biotech, Biopharmaceutical, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2017 | 2018 |
| Headquarters | New York, United States | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Immunyx Pharma | NewStem |
|---|---|---|
| Employees | 6 | Not published |
| Headcount growthLast 12 months | +6.0% | Not published |
| Total funding | Not published | $30.0M |
| Latest round | Not published | Series B |
| LinkedIn followers | 858 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunyx Pharma | NewStem |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 46/100 | 45/100 |
| Traction | 8/100 | 37/100 |
| Team | 60/100 | 30/100 |
| Search visibility | 32/100 | 9/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (41/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 6/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunyx Pharma | NewStem |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
Immunyx Pharma vs NewStem: common questions
Which is better, Immunyx Pharma or NewStem?
On our 0-100 score Immunyx Pharma rates higher (46/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Immunyx Pharma and NewStem compare on the numbers?
Immunyx Pharma leads on domain rating (6/100 against 4/100). NewStem leads on agent readiness (50/100 against 41/100).
Read the full Immunyx Pharma review and pricing or the NewStem review and pricing. You can also browse other Immunyx Pharma alternatives we track.